Genenta Science SPA- 詳細介紹、公司背景、業務範圍、財務數據以及市場表現

關於 Genenta Science SPA 公司

Genenta Science SpA is an Italy-based company engaged in clinical-stage biotechnology research. The Company focuses on the development of lentivirus-based gene and cell therapies in cancer. It uses gene-based cytokine delivery to activate the immune system within the tumor providing the anti-tumor response. The Company not only operates locally but also is present in global markets, including the United States.

Genenta Science SPA簡介



公司代碼GNTA

公司名稱Genenta Science SPA

上市日期Dec 15, 2021

CEOParacchi (Pierluigi)

員工數量13

證券類型Depository Receipt

年結日Dec 15

公司地址Via Olgettina 58

城市MILANO

上市交易所NASDAQ OMX - NASDAQ BASIC

國家Italy

郵編20132

電話

網址https://www.genenta.com/

公司代碼GNTA

上市日期Dec 15, 2021

CEOParacchi (Pierluigi)

Genenta Science SPA公司高管



名稱

名稱/職務

職務

持股

持股變動

Mr. Pierluigi Paracchi

Chairman of the Board, Chief Executive Officer, General Manager

2.30M

+6387.00%

Dr. Carlo Russo, M.D.

Chief Medical Officer, Head of Development

602.42K

+4000.00%

Mr. Richard B. Slansky

Chief Financial Officer

22.15K

+2200.00%

Dr. Stefania Mazzoleni, Ph.D.

Scientific Project Manager, Communication Officer

--

Dr. John Louis Cantello, Ph.D.

Independent Director

--

Dr. Lauren Haeyong Chung, Ph.D.

Independent Director

--

Dr. Armon Reza Sharei, Ph.D.

Independent Director

--

Dr. Todd Wider, M.D.

Independent Director

--

Ms. Barbara Regonini

Finance Director

--

名稱

名稱/職務

職務

持股

持股變動

Mr. Pierluigi Paracchi

Chairman of the Board, Chief Executive Officer, General Manager

2.30M

+6387.00%

Dr. Carlo Russo, M.D.

Chief Medical Officer, Head of Development

602.42K

+4000.00%

Mr. Richard B. Slansky

Chief Financial Officer

22.15K

+2200.00%

Dr. Stefania Mazzoleni, Ph.D.

Scientific Project Manager, Communication Officer

--

Dr. John Louis Cantello, Ph.D.

Independent Director

--

Dr. Lauren Haeyong Chung, Ph.D.

Independent Director

--

收入明細

由於公司未披露，未能獲取相關數據

由於公司未披露，未能獲取相關數據

業務

地區

由於公司未披露，未能獲取相關數據

股東統計

更新時間: 2月1日週日

持股股東

股東類型

持股股東

佔比

Paracchi (Pierluigi)

12.03%

IRCCS Ospedale San Raffaele

9.91%

Naldini (Luigi M.D., Ph.D.)

7.24%

Gentner (Bernard)

3.62%

Russo (Carlo)

3.15%

其他

64.06%

持股股東

佔比

Paracchi (Pierluigi)

12.03%

IRCCS Ospedale San Raffaele

9.91%

Naldini (Luigi M.D., Ph.D.)

7.24%

Gentner (Bernard)

3.62%

Russo (Carlo)

3.15%

其他

64.06%

股東類型

持股股東

佔比

Individual Investor

26.30%

Corporation

9.91%

Investment Advisor

5.52%

Investment Advisor/Hedge Fund

2.23%

Holding Company

1.22%

Sovereign Wealth Fund

1.18%

Hedge Fund

0.59%

Bank and Trust

0.02%

Research Firm

0.01%

其他

53.03%

機構持股



更新時間: 1月1日週四

報告期間

機構數

持股數

持股佔比

持股變動

2025Q4

19

1.83M

9.54%

-414.06K

2025Q3

16

1.96M

10.22%

-334.32K

2025Q2

24

9.06M

49.52%

-260.05K

2025Q1

28

9.12M

49.85%

-26.40K

2024Q4

28

8.70M

47.57%

-293.74K

2024Q3

26

8.60M

47.05%

-368.88K

2024Q2

26

8.48M

46.40%

-155.29K

2024Q1

25

8.51M

46.63%

+417.20K

2023Q4

25

8.38M

45.98%

+434.51K

2023Q3

24

8.11M

44.52%

+167.75K

股東持股明細



名稱

持股數

佔比

持股變動

變動比例

公告日期

Paracchi (Pierluigi)

2.30M

11.99%

-3.10K

-0.13%

Mar 26, 2025

IRCCS Ospedale San Raffaele

1.90M

9.91%

--

Mar 26, 2025

Naldini (Luigi M.D., Ph.D.)

1.39M

7.24%

--

Mar 26, 2025

Gentner (Bernard)

692.87K

3.62%

--

Mar 26, 2025

Russo (Carlo)

602.42K

3.15%

+4.00K

+0.67%

Mar 26, 2025

Eurizon Capital SGR S.p.A.

360.00K

1.88%

--

Nov 30, 2025

Kairos Partners SGR S.p.A.

335.61K

1.75%

-24.00

-0.01%

Jun 30, 2025

Investitori SGR S.p.A.

234.05K

1.22%

--

Nov 30, 2025

Allianz SE

234.05K

1.22%

--

Sep 30, 2025

Norges Bank Investment Management (NBIM)

311.74K

1.63%

+18.91K

+6.46%

Jun 30, 2025

持股ETF



機構名稱

佔比

暫無數據

分紅派息



近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股



公告日期

除權除息日

類型

比率

暫無數據

公告日期

除權除息日

類型

比率

暫無數據